521 related articles for article (PubMed ID: 11482743)
1. Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.
Senard JM; Brefel-Courbon C; Rascol O; Montastruc JL
Drugs Aging; 2001; 18(7):495-505. PubMed ID: 11482743
[TBL] [Abstract][Full Text] [Related]
2. [Blood pressure disorders during idiopathic Parkinson's disease].
Senard JM
Presse Med; 2003 Aug; 32(26):1231-7. PubMed ID: 14506467
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management.
Pathak A; Senard JM
Expert Rev Cardiovasc Ther; 2004 May; 2(3):393-403. PubMed ID: 15151485
[TBL] [Abstract][Full Text] [Related]
4. Treatment of orthostatic hypotension.
Freeman R
Semin Neurol; 2003 Dec; 23(4):435-42. PubMed ID: 15088264
[TBL] [Abstract][Full Text] [Related]
5. Ambulatory 24-hour blood pressure recordings in patients with Parkinson's disease with or without fludrocortisone.
Hakamäki T; Rajala T; Lehtonen A
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):367-9. PubMed ID: 9707350
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management.
Pathak A; Senard JM
Expert Rev Neurother; 2006 Aug; 6(8):1173-80. PubMed ID: 16893345
[TBL] [Abstract][Full Text] [Related]
7. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
Isaacson SH; Skettini J
Vasc Health Risk Manag; 2014; 10():169-76. PubMed ID: 24729712
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic treatment of orthostatic hypotension.
Park JW; Okamoto LE; Shibao CA; Biaggioni I
Auton Neurosci; 2020 Dec; 229():102721. PubMed ID: 32979782
[TBL] [Abstract][Full Text] [Related]
9. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
Kremens D; Lew M; Claassen D; Goodman BP
Clin Auton Res; 2017 Jul; 27(Suppl 1):29-31. PubMed ID: 28674867
[No Abstract] [Full Text] [Related]
10. Neurogenic orthostatic hypotension of Parkinson's disease: what exploration for what treatment?
Senard JM; Pathak A
Rev Neurol (Paris); 2010 Oct; 166(10):779-84. PubMed ID: 20817229
[TBL] [Abstract][Full Text] [Related]
11. Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic?
Merola A; Romagnolo A; Rosso M; Lopez-Castellanos JR; Wissel BD; Larkin S; Bernardini A; Zibetti M; Maule S; Lopiano L; Espay AJ
Parkinsonism Relat Disord; 2016 Dec; 33():65-71. PubMed ID: 27641792
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.
Shibao CA; Kaufmann H
CNS Drugs; 2017 Nov; 31(11):975-989. PubMed ID: 29076058
[TBL] [Abstract][Full Text] [Related]
13. Orthostatic hypotension: evaluation and treatment.
Maule S; Papotti G; Naso D; Magnino C; Testa E; Veglio F
Cardiovasc Hematol Disord Drug Targets; 2007 Mar; 7(1):63-70. PubMed ID: 17346129
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of orthostatic hypotension in Parkinson's disease.
Senard JM; Raï S; Lapeyre-Mestre M; Brefel C; Rascol O; Rascol A; Montastruc JL
J Neurol Neurosurg Psychiatry; 1997 Nov; 63(5):584-9. PubMed ID: 9408097
[TBL] [Abstract][Full Text] [Related]
15. Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease.
Hellman AM; Shah SP; Pawlowski SM; Duda JE; Morley JF
Parkinsonism Relat Disord; 2015 Jul; 21(7):723-8. PubMed ID: 25940998
[TBL] [Abstract][Full Text] [Related]
16. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
Parkinsonism Relat Disord; 2006 Jun; 12(5):284-8. PubMed ID: 16549383
[TBL] [Abstract][Full Text] [Related]
17. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.
Mathias CJ
Clin Auton Res; 2008 Mar; 18 Suppl 1():25-9. PubMed ID: 18368304
[TBL] [Abstract][Full Text] [Related]
18. Orthostatic intolerance--an expression of autonomic disfunction in Parkinson's disease.
Dumbravă EL; Cojocaru DC; Postolache P
Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):75-80. PubMed ID: 24741779
[TBL] [Abstract][Full Text] [Related]
19. Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension.
Keating GM
Drugs; 2015 Feb; 75(2):197-206. PubMed ID: 25559422
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E
Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
